BIOMAT Database Logo BIOMAT Database Logo

Response to Cytoplasmic rods and rings in ribavirin and Cytoplasmic rods and rings in mycophenolic acid treatment. 2017

Jordan J Feld, and Jean-Michel Pawlotsky, and Fernando Tatsch, and Mark Sulkowski, and Fred Poordad, and Ira Jacobson
Toronto Centre for Liver Disease, University Health Network, University of Toronto, Toronto, ON, Canada.

UI MeSH Term Description Entries
D009173 Mycophenolic Acid Compound derived from Penicillium stoloniferum and related species. It blocks de novo biosynthesis of purine nucleotides by inhibition of the enzyme inosine monophosphate dehydrogenase (IMP DEHYDROGENASE). Mycophenolic acid exerts selective effects on the immune system in which it prevents the proliferation of T-CELLS, LYMPHOCYTES, and the formation of antibodies from B-CELLS. It may also inhibit recruitment of LEUKOCYTES to sites of INFLAMMATION. Cellcept,Mycophenolate Mofetil,Mycophenolate Mofetil Hydrochloride,Mycophenolate Sodium,Mycophenolic Acid Morpholinoethyl Ester,Myfortic,RS 61443,RS-61443,Sodium Mycophenolate,Mofetil Hydrochloride, Mycophenolate,Mofetil, Mycophenolate,Mycophenolate, Sodium,RS61443
D003593 Cytoplasm The part of a cell that contains the CYTOSOL and small structures excluding the CELL NUCLEUS; MITOCHONDRIA; and large VACUOLES. (Glick, Glossary of Biochemistry and Molecular Biology, 1990) Protoplasm,Cytoplasms,Protoplasms
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012254 Ribavirin A nucleoside antimetabolite antiviral agent that blocks nucleic acid synthesis and is used against both RNA and DNA viruses. Ribovirin,Tribavirin,ICN-1229,Rebetol,Ribamide,Ribamidil,Ribamidyl,Ribasphere,Vilona,Viramide,Virazide,Virazole,ICN 1229,ICN1229
D016898 Interferon-alpha One of the type I interferons produced by peripheral blood leukocytes or lymphoblastoid cells. In addition to antiviral activity, it activates NATURAL KILLER CELLS and B-LYMPHOCYTES, and down-regulates VASCULAR ENDOTHELIAL GROWTH FACTOR expression through PI-3 KINASE and MAPK KINASES signaling pathways. Interferon Alfa,Interferon, Leukocyte,Interferon, Lymphoblast,alpha-Interferon,IFN-alpha D,IFN-alpha5,Interferon alpha-1,Interferon alpha-17,Interferon alpha-4,Interferon alpha-5,Interferon alpha-7,Interferon alpha-88,Interferon alpha-J,Interferon alpha-T,Interferon alpha4,Interferon alpha5,Interferon, Lymphoblastoid,Interferon, alpha,LeIF I,LeIF J,Leif D,IFN alpha D,IFN alpha5,Interferon alpha,Interferon alpha 1,Interferon alpha 17,Interferon alpha 4,Interferon alpha 5,Interferon alpha 7,Interferon alpha 88,Interferon alpha J,Interferon alpha T,Leukocyte Interferon,Lymphoblast Interferon,Lymphoblastoid Interferon,alpha Interferon
D019698 Hepatitis C, Chronic INFLAMMATION of the LIVER in humans that is caused by HEPATITIS C VIRUS lasting six months or more. Chronic hepatitis C can lead to LIVER CIRRHOSIS. Chronic Hepatitis C

Related Publications

Jordan J Feld, and Jean-Michel Pawlotsky, and Fernando Tatsch, and Mark Sulkowski, and Fred Poordad, and Ira Jacobson
Cytoplasmic rods and rings in mycophenolic acid treatment.
November 2017, Liver international : official journal of the International Association for the Study of the Liver,
Jordan J Feld, and Jean-Michel Pawlotsky, and Fernando Tatsch, and Mark Sulkowski, and Fred Poordad, and Ira Jacobson
Cytoplasmic rods and rings in ribavirin treatment.
November 2017, Liver international : official journal of the International Association for the Study of the Liver,
Jordan J Feld, and Jean-Michel Pawlotsky, and Fernando Tatsch, and Mark Sulkowski, and Fred Poordad, and Ira Jacobson
Temporal evolution of human autoantibody response to cytoplasmic rods and rings structure during anti-HCV therapy with ribavirin and interferon-α.
October 2014, Immunologic research,
Jordan J Feld, and Jean-Michel Pawlotsky, and Fernando Tatsch, and Mark Sulkowski, and Fred Poordad, and Ira Jacobson
Cytoplasmic rods and rings autoantibodies developed during pegylated interferon and ribavirin therapy in patients with chronic hepatitis C.
January 2012, Antiviral therapy,
Jordan J Feld, and Jean-Michel Pawlotsky, and Fernando Tatsch, and Mark Sulkowski, and Fred Poordad, and Ira Jacobson
Sindbis virus mutants resistant to mycophenolic acid and ribavirin.
May 1987, Virology,
Jordan J Feld, and Jean-Michel Pawlotsky, and Fernando Tatsch, and Mark Sulkowski, and Fred Poordad, and Ira Jacobson
Longitudinal study of a human drug-induced model of autoantibody to cytoplasmic rods/rings following HCV therapy with ribavirin and interferon-α.
January 2012, PloS one,
Jordan J Feld, and Jean-Michel Pawlotsky, and Fernando Tatsch, and Mark Sulkowski, and Fred Poordad, and Ira Jacobson
Autoantibodies to cytoplasmic rods and rings in patients with hepatitis C virus infection treated with direct-acting antivirals: The role of prior treatment with interferon plus ribavirin.
February 2019, Gastroenterologia y hepatologia,
Jordan J Feld, and Jean-Michel Pawlotsky, and Fernando Tatsch, and Mark Sulkowski, and Fred Poordad, and Ira Jacobson
Inhibition of dengue virus replication by mycophenolic acid and ribavirin.
July 2006, The Journal of general virology,
Jordan J Feld, and Jean-Michel Pawlotsky, and Fernando Tatsch, and Mark Sulkowski, and Fred Poordad, and Ira Jacobson
Interferon-ribavirin therapy induces serum antibodies determining 'rods and rings' pattern in hepatitis C patients.
December 2014, Journal of viral hepatitis,
Jordan J Feld, and Jean-Michel Pawlotsky, and Fernando Tatsch, and Mark Sulkowski, and Fred Poordad, and Ira Jacobson
Anti-rods/rings autoantibody generation in hepatitis C patients during interferon-α/ribavirin therapy.
February 2016, World journal of gastroenterology,
Copied contents to your clipboard!